These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 11267291)
1. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. Sperschneider H; Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291 [No Abstract] [Full Text] [Related]
2. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study. Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907 [No Abstract] [Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP; Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up. Montagnino G; Krämer BK; Arias M; Transplant Proc; 2002 Aug; 34(5):1635-7. PubMed ID: 12176515 [No Abstract] [Full Text] [Related]
5. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression. Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909 [No Abstract] [Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Margreiter R; Lancet; 2002 Mar; 359(9308):741-6. PubMed ID: 11888584 [TBL] [Abstract][Full Text] [Related]
7. Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles. Henry ML Clin Transplant; 1999 Jun; 13(3):209-20. PubMed ID: 10383101 [TBL] [Abstract][Full Text] [Related]
8. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience. Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911 [No Abstract] [Full Text] [Related]
9. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report. Jurewicz WA Transplant Proc; 1999 Nov; 31(7A):64S-66S. PubMed ID: 10576048 [No Abstract] [Full Text] [Related]
10. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497 [No Abstract] [Full Text] [Related]
11. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients. Dudley CR; Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179 [No Abstract] [Full Text] [Related]
12. Current advantage of FK 506 in cadaveric kidney transplantation. Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207 [No Abstract] [Full Text] [Related]
13. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536 [TBL] [Abstract][Full Text] [Related]
14. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Friemann S; Feuring E; Padberg W; Ernst W Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504 [No Abstract] [Full Text] [Related]
15. Four-year follow-up of the European Tacrolimus Multicenter Renal Study. Mayer AD Transplant Proc; 1999 Nov; 31(7A):27S-28S. PubMed ID: 10576038 [No Abstract] [Full Text] [Related]
16. Tacrolimus in solid organ transplantation: an update. Shapiro R Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545 [No Abstract] [Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial. Saudek F; Malaise J; Boucek P; Adamec M; Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547 [TBL] [Abstract][Full Text] [Related]
18. Analysis of primary and recurrent rejection following renal transplantation in a large, comparative, multicentre trial. Del Castillo D Transplant Proc; 2001; 33(1-2):1259-61. PubMed ID: 11267283 [No Abstract] [Full Text] [Related]
19. Use of tacrolimus in renal transplantation. van Hooff JP; Christiaans MH Transplant Proc; 1999 Dec; 31(8):3298-9. PubMed ID: 10616483 [TBL] [Abstract][Full Text] [Related]
20. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233 [No Abstract] [Full Text] [Related] [Next] [New Search]